Characterizations of coronavirus cis-acting RNA elements and the transcription step affecting its transcription efficiency

Virology

Volumn 243, Issue 1, 1998, Pages 198-207

  An, Sungwhan ^a   Makino, Shinji ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; MESSENGER RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; RNA SYNTHESIS; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION;

ANIMALIA; CORONAVIRUS; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0032579771     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9059     Document Type: Article

References (36)

1. Baric R. S., Stohlman S. A., Lai M. M. C. Characterization of replicative intermediate RNA of mouse hepatitis virus: Presence of leader RNA sequences on nascent chains. J. Virol. 48:1983;633-640.
2. de Vries A. A. F., Chirnside E. D., Bredenbeek P. J., Gravestein L. A., Horzinek M. C., Spaan W. J. M. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res. 18:1990;3241-3247.
3. Fischer F., Stegen C. F., Koetzner C. A., Masters P. S. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J. Virol. 71:1997;5148-5160.
4. Furuya T., Lai M. M. C. Three different cellular proteins bind to complementary sites on the 5′-end-positive and 3′-end negative strands of mouse hepatitis virus RNA. J. Virol. 67:1993;7215-7222.
5. Higuchi R. Recombinant PCR. PCR Protocols. 1990;Academic Press, San Diego. p. 177-183.
6. Hirano N., Fujiwara K., Hino S., Matsumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte. Virusforch. 44:1974;298-302.
7. Jeong Y. S., Makino S. Mechanism of coronavirus transcription: Duration of primary transcription initiation activity and effect of subgenomic RNA transcription on RNA replication. J. Virol. 66:1992;3339-3346.
8. Jeong Y. S., Makino S. Evidence for coronavirus discontinuous transcription. J. Virol. 68:1994;2615-2623.
9. Jeong Y. S., Repass J. F., Kim Y.-N., Hwang S. M., Makino S. Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology. 217:1996;311-322.
10. Joo M., Makino S. Mutagenic analysis of the coronavirus intergenic consensus sequence. J. Virol. 66:1992;6330-6337.
11. Joo M., Makino S. The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J. Virol. 69:1995;272-280.
12. Kim Y.-N., Jeong Y. S., Makino S. Analysis ofcis. Virology. 197:1993;53-63.
13. Kim Y.-N., Makino S. Characterization of a murine coronavirus defective interfering RNA internalcis. J. Virol. 69:1995;4963-4971.
14. Lai M. M. C., Baric R. S., Brayton P. R., Stohlman S. A. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA. 81:1984;3626-3630.
15. Lai M. M. C., Brayton P. R., Armen R. C., Patton C. D., Pugh C., Stohlman S. A. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J. Virol. 39:1981;823-834.
16. Lai M. M. C., Patton C. D., Baric R. S., Stohlman S. A. Presence of leader sequences in the mRNA of mouse hepatitis virus. J. Virol. 46:1983;1027-1033.
17. Leibowitz J. L., Wilhelmsen K. C., Bond C. W. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM. Virology. 114:1981;39-51.
18. Liao C.-L., Lai M. M. C. Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 68:1994;4727-4737.
19. Lin Y.-J., Lai M. M. C. Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J. Virol. 67:1993;6110-6118.
20. Lin Y.-J., Liao C.-L., Lai M. M. C. Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: Implication for the role of minus-strand RNA in RNA replication and transcription. J. Virol. 68:1994;8131-8140.
21. Lin Y.-J., Zhang X., Wu R.-C., Lai M. M. C. The 3′ untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J. Virol. 70:1996;7236-7240.
22. Makino S., Joo M. Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J. Virol. 67:1993;3304-3311.
23. Makino S., Joo M., Makino J. K. A system for study of coronavirus mRNA synthesis: A regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65:1991;6031-6041.
24. Makino S., Lai M. M. C. Evolution of the 5′-end of genomic RNA of murine coronaviruses during passagesin vitro. Virology. 169:1989a;227-232.
25. Makino S., Lai M. M. C. High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J. Virol. 63:1989b;5285-5292.
26. Makino S., Taguchi F., Hirano N., Fujiwara K. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology. 139:1984;138-151.
27. Sawicki S. G., Sawicki D. L. Coronavirus transcription: Subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 64:1990;1050-1056.
28. Schaad M. C., Baric R. S. Genetics of mouse hepatitis virus transcription: Evidence that subgenomic negative strands are functional templates. J. Virol. 68:1994;8169-8179.
29. Sethna P. B., Hofmann M. A., Brian D. A. Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J. Virol. 65:1991;320-325.
30. Sethna P. B., Hung S.-L., Brian D. A. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. Natl. Acad. Sci. USA. 86:1989;5626-5630.
31. Shieh C.-K., Lee H.-J., Yokomori K., La Monica N., Makino S., Lai M. M. C. Identification of a new transcription initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J. Virol. 63:1989;3729-3736.
32. Spaan W., Delius H., Skinner M., Armstrong J., Rottier P., Smeekens S., van der Zeijst B. A. M., Siddell S. G. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J. 2:1983;1939-1944.
33. van der Most, R. G. de Groot, R. J. Spaan, W. J. M. 1994, Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: A study of coronavirus transcription initiation, 68, 3656, 3666.
34. van Marle G., Luytjes W., van der Most R. G., van der Straaten T., Spaan W. J. M. Regulation of coronavirus mRNA transcription. J. Virol. 69:1995;7851-7856.
35. Winship P. R. An improved method for directly sequencing PCR material using dimethyl sulfoxide. Nucleic Acids Res. 17:1989;1266.
36. Zhang X., Liao C. J., Lai M. M. C. Coronavirus leader RNA regulates and initiates subgenomic mRNA both in trans and in cis. J. Virol. 68:1994;4738-4746.